Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem in fibromyalgia
NCT00371137Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Aug 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Placebo with Xyrem (2 arms). Primary endpoint: Visual Analog Scale Pain Response at 14 weeks. Started Aug 2006; status: completed.
02
Drugs
sodium oxybate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00371137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371137.